You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

ESTAZOLAM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Estazolam

A generic version of ESTAZOLAM was approved as estazolam by NOVITIUM PHARMA on July 3rd, 1997.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ESTAZOLAM?
  • What are the global sales for ESTAZOLAM?
  • What is Average Wholesale Price for ESTAZOLAM?
Drug patent expirations by year for ESTAZOLAM
Drug Prices for ESTAZOLAM

See drug prices for ESTAZOLAM

Recent Clinical Trials for ESTAZOLAM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The First Affiliated Hospital with Nanjing Medical UniversityN/A
Haitao TuPhase 4
The First Affiliated Hospital, Guangzhou University of Traditional Chinese MedicinePhase 4

See all ESTAZOLAM clinical trials

Pharmacology for ESTAZOLAM
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for ESTAZOLAM
Anatomical Therapeutic Chemical (ATC) Classes for ESTAZOLAM

US Patents and Regulatory Information for ESTAZOLAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Sa ESTAZOLAM estazolam TABLET;ORAL 074921-001 Jul 10, 1997 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novitium Pharma ESTAZOLAM estazolam TABLET;ORAL 074826-002 Jul 3, 1997 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Dr Reddys Labs Sa ESTAZOLAM estazolam TABLET;ORAL 074921-002 Jul 10, 1997 AB RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.